HOME >> MEDICINE >> NEWS
Vitamin supplementation could slow arteriosclerosis in heart-transplant patients

A US randomised trial in this weeks issue of THE LANCET suggests that vitamin C and E supplementation could be of clinical benefit in delaying the onset of arteriosclerosis in the first year after heart transplantation.

Around 70% of patients develop arteriosclerosis within three years after heart transplantation, which is thought to be associated with oxidant stress. James Fang and colleagues from Brigham and Women's Hospital, Boston, USA, proposed that treatment with antioxidant vitamins C and E would slow the progression of transplant-associated arteriosclerosis.

40 patients (0-2 years after heart transplantation) were randomly assigned vitamin C 500 mg plus vitamin E 400 IU, each twice daily, or placebo, for 1 year. The primary endpoint was the change in average intimal index (plaque area divided by vessel area) measured by intravascular ultrasonography (IVUS). Coronary endothelium-dependent vasoreactivity was assessed with intracoronary acetylcholine infusions. IVUS, coronary vasoreactivity, and vitamin C and E plasma concentrations were assessed at baseline and at 1 year follow-up.

Vitamin C and E concentrations increased in the treatment group, but not in the placebo group, as expected. During 1 year of treatment, the intimal index increased in the placebo group by 8% but did not change significantly in the treatment group. Coronary endothelial function remained stable in both groups.

James Fang comments: Our results suggest that vitamins C and E provide a clinically useful approach to reducing arteriosclerosis after cardiac transplantation. Antioxidant therapy with these vitamins may also be useful in other solid-organ allografts, such as kidney, lung, and liver transplants, in which obliteration of vascular or tubular structures limits long-term success. Further investigations are warranted to investigate whether the beneficial effects of vitamins C and E are sustained over many years when most of the clinical complicat
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
28-Mar-2002


Page: 1 2

Related medicine news :

1. Vitamin E may not prevent cancer or cardiovascular events, but may increase risk for heart failure
2. Vitamin C reduces level of C-reactive protein, finds UC Berkeley-led study
3. Vitamins good for some older women/bad for others
4. Vitamin B-12 levels linked to bone loss in aging women
5. Vitamin supplement use may reduce effects of Alzheimers disease
6. Vitamins help treat depression
7. Vitamin D deficiency emerges as new epidemic
8. Vitamins C and E improve cardiovascular health in children with high cholesterol, study says
9. Vitamins C and E may enhance effectiveness of insulin for diabetes
10. Vitamins valuable for baby boomers eye disease
11. Vitamin E fails to join heart-health regimen

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... 19, 2019 , ... WEDI , the nation’s leading nonprofit authority on ... statutory advisor to the U.S. Department of Health and Human Services (HHS), today issued ... was issued following the release last week at the HIMSS Global Conference and Exhibition ...
(Date:2/19/2019)... ... 2019 , ... In one of the first research studies ... team led by a Worcester Polytechnic Institute professor found that women who experience ... weight gain during pregnancy, and weight retention after their baby is born. , ...
(Date:2/19/2019)... ... February 19, 2019 , ... Dr. Alejandro ... patients with or without a referral who are interested in full arch permanent ... Kovacs routinely places All-on-4® dental implants in Texarkana, TX, for those ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... ... opioid epidemic with town halls across the country , A partnership between Liberty ... nationwide opioid crisis, continues with its next town hall event on Tuesday, February ...
(Date:2/19/2019)... ... February 19, 2019 , ... Catalent ... solutions for drugs, biologics and consumer health products, today announced that Michael ... Bioassay Conference of the BioPharmaceutical Emerging Best Practices Association (BEBPA), taking place ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... , ... February 19, 2019 , ... ... cure for Job Syndrome by providing the scientific community with additional opportunities to ... Alain Fischer as Chief Scientific Officer of the Foundation’s Scientific Advisory Board and ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... RCH ... firms of all sizes, announces the hiring of Frank Iafrato as Director of Sales ... to deepen the firm’s sales coverage throughout the Northeast region, building upon the momentum ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... for gum disease that utilizes modern dental lasers. The Laser Assisted New Attachment ... bacteria and diseased tissue, the leading cause of gum disease. Dr. Farahmand is ...
Breaking Medicine Technology:
Cached News: